EE70 Real-World Comparison of Healthcare Resource Utilization and Costs Between Patients with Chronic Lymphocytic Leukemia Treated with First-Line Ibrutinib or Acalabrutinib

Abstract

Authors

K.A. Rogers Z.P. Qureshi Z. Ding B. Emond P. Gogna M.H. Lafeuille A. Bokun M. Fradley